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CPI was applied to patients in the Endovascular Aneurysm Repair
(EVAR) I and II trials. The effect of fitness and type of AA repair was
determined with respect to elective 30-day mortality and 4-year survival.
The mean (SD) CPI scores were 3.6 (9.3) for 1252 EVAR I patients
and 10.0 (11.3) for 404 EVAR II patients; range –25 to43 (P .001). Of
these, 579 EVAR I patients were classified as good fitness (mean CPI, –4.2),
331 were classified as moderate fitness (mean CPI, 5.7), and 338 patients
were classified as poor fitness (mean CPI, 15.1). Only in the good fitness
group did 30-day mortality convincingly favor endovascular repair (odds
ratio, 0.24; P  .030). The overall test of interaction was not significant (P
 .363). For 4-year all-cause and aneurysm-related mortality, there was no
benefit for either treatment across all fitness scores (P  .281 and P  .371
respectively).
Comment: It is a little surprising and somewhat counterintuitive
that sustained benefit for aneurysm-related mortality in EVAR patients
was most convincing in the fittest patients. However, the number of
deaths 30 days in the EVAR patients (10 of 610) and patients under-
going open repair (25 of 596) was small. This makes precise and
dogmatic interpretation of the data somewhat difficult. However, as the
authors point out, the data certainly do not allow one to conclude that
fitter patients benefit from open surgery compared with EVAR. In fact,
the opposite may be true.
Final Twelfth-Year Follow-up of Surgery vs Surveillance in the UK
Small Aneurysm Trial
UK Small Aneurysm Trial Participants. Br J Surg 2007;94:702-8.
Conclusion: There is no long-term survival benefit of early elective
open repair of small abdominal aortic aneurysms (AAAs). Patients still have
higher mortality rates after successful AAA repair than the general popula-
tion.
Summary: This represents the final follow-up of the UK Small Aneu-
rysm Trial. The trial was designed to determine whether early open surgical
repair benefited patients with small AAAs. The UK Small Aneurysm Trial
randomized 1276 patients between the ages of 60 and 76 years who were
considered fit for surgery to immediate repair of an infrarenal AAA between
4.0 and 5.5 cm or ultrasound surveillance. Aneurysms in the surveillance
group were repaired once they reached a diameter 5.5 cm, became
symptomatic, or demonstrated a worrisome growth rate.
Of the 1276 patients identified and potentially eligible for the study,
1090 patients were enrolled between 1991 and 1995. They were fol-
lowed up for aneurysm repair and mortality until November 2005. By
November 2005, 65.5% of the patients (n  714) had died, 85.2% had
undergone aneurysm repair, 13.8% (n  150) died without aneurysm
repair, and 1% were still alive without aneurysm repair. Overall mortality
was 63.9% in the surgery group and 67.3% in the surveillance group
(unadjusted hazard ratio, 0.90; P  .139). Three-fourths of the patients
in the surveillance group eventually had aneurysm repair. The 30-day
mortality rate for elective repair was 6.3% in the surveillance group and
5.0% in the early surgery group (P  .366). Cost estimates suggest a 17%
higher cost in the early surgery group. The death rate of patients in the
UK Small Aneurysm Trial was about twice that of the population
matched for age and sex.
Comment: The UK Small Aneurysm Trial and others had already
proven that early open repair of small AAAs has no early survival benefit.
There is now clearly no late survival benefit, either. Given the high rate of
mortality in AAA patients compared with the general population, perhaps
the greatest benefit of AAA screening will be the identification of another
group of patients who should be targeted for vigorous cardiovascular
risk-factor reduction.
Outcome Following Bypass and Proximal and Distal Ligation of Pop-
liteal Aneurysms
Box B, Adamson M, Magee TR. Br J Surg 2007;94:179-82.
Conclusion: Treatment of popliteal aneurysms with proximal and
distal ligation and intervening bypass produces excellent long-term patency
and exclusion of the popliteal aneurysm.
Summary: Ligation of popliteal aneurysms should exclude them from
the circulation. Recent studies have suggested, however, that one-third of
popliteal aneurysms treated by bypass and ligation/exclusion can develop or
retain flow after operation (J Vasc Surg 2003;37:958-59, Br J Surg 2004;
91:174-7). Nevertheless, proximal and distal ligation and bypass have re-
mained the standard for treatment of popliteal aneurysms.
The authors identified 116 patients with popliteal aneurysms, 66 of
whom were treated with bypass and ligation. Postoperative graft patency
was determined by duplex surveillance. Seventeen patients with bypassed
popliteal arteries underwent 33 duplex scans to examine for persistent
flow within the aneurysm sac and an increase in size of the popliteal
aneurysm.
When the popliteal artery was patent preoperatively, 3-, 5-, and 8-year
primary patency rates for bypass grafting were 78%, 78%, and 51%, respec-
tively. The rates did not differ from those obtained after bypass for throm-
bosed popliteal aneurysms, with 3- and 5-year primary patency being 72%
and 65%. In this study, no popliteal aneurysm produced further symptoms
after bypass and ligation. Duplex imaging did not reveal any flow in any
bypassed and excluded popliteal aneurysm during follow-up. One aneurysm
did show an increase in size.
Comment: The authors’ data contrast with recent studies suggest-
ing residual flow within the popliteal aneurysm and aneurysm growth in
some patients after proximal and distal ligation and intervening bypass
for popliteal aneurysm. It is unclear why their observations differ from
other recent studies. The authors suggest that the proximal and distal
sites of ligation be as close as possible to the popliteal aneurysm. Only a
few of their patients received follow-up imaging; therefore, the true
incidence of maintained patency of the popliteal aneurysm cannot be
determined. The authors reported no residual symptoms in their pa-
tients, however, and one can argue follow-up imaging of the popliteal
artery after repair of the aneurysm is unnecessary if the patient is
asymptomatic.
Inflammatory Abdominal Aortic Aneurysm: Predictors of Long-Term
Outcome in a Case-Control Study
Yusuf K, Murat B, Unal A, et al. Surgery 2007;141:83-9.
Conclusion: Persistent signs of inflammation after repair of an
inflammatory abdominal aortic aneurysm (IAAA), with or without retro-
peritoneal fibrosis, place a patient with IAAA at high risk for poor,
long-term outcome.
Summary: The authors sought to determine which features play a
role in determining long-term outcome in patients with IAAA. IAAA was
present in 17 of 238 patients (7.1%) who were operated for AAA from
1990 to 1997 at the authors’ institution. The patients with IAAA were
matched with a group of 35 patients with noninflammatory AAAs for age,
gender, and preoperative risk factors. Risk-factor analysis was determined
for poor outcome in the patients with IAAA vs those with noninflamma-
tory AAA.
Operations were performed through a midline incision. Clinical char-
acteristics and preoperative risk factors in the patients with AAA vs those
with IAAA were not significantly different. All patients with IAAA were
symptomatic. Patients with IAAA had larger aneurysms compared with
those with noninflammatory AAA (8.2 1.2 cm vs 6.1 0.4 cm, P .04).
The preoperative erythrocyte sedimentation rate was elevated in the patients
with IAAA compared with those with noninflammatory AAA (mean, 48 
14 mm/h vs 8  3 mm/h, P  .01). There was no difference in surgical
morbidity, mortality, intensive care unit, or hospital stay in the inflammatory
vs the noninflammatory AAA groups. Survival at 8 years was worse in the
inflammatory vs noninflammatory AAA group (60% vs 74%, P .01). A high
sedimentation rate after surgical intervention (P .02), presence of cardio-
vascular disease (P .01), and postoperative chronic renal failure (P .02)
were all independent risk factors for death in the IAAA group. No other
variables analyzed were statistically positive for adversely affecting long-term
mortality.
Comment: The two interesting features of this report are, first of all,
that despite similar preoperative morbidity and mortality, long-term mor-
tality in patients with IAAA appears to be greater than that of patients with
noninflammatory AAA, and this mortality is associated with signs of persist-
ing inflammation. Closer postoperative follow-up may be warranted in
patients with IAAA treated by open surgical reconstruction than for patients
treated for noninflammatory AAA.
Comparison of Risk-Adjusted 30-Day Postoperative Mortality and
Morbidity in Department of Veterans Affairs Hospitals and Selected
University Medical Centers: Vascular Surgical Operations in Men
Hutter MM, Lancaster RT, Henderson WG, et al. J Am Coll Surg 2007;
204:1115-26.
Conclusion: Risk-adjusted 30-day morbidity for vascular surgical op-
erations inmen is lower in Veterans Affairs (VA) hospitals compared with the
private sector. There is no difference in risk-adjusted mortality rates between
the two types of institution.
Summary: A congressional mandate required risk-adjusted surgical
outcomes in Department of Veterans Affairs hospitals to be compared with
those of private sector hospitals. In this regard, the National Surgical Quality
Improvement Program (NSQIP) was initiated in the VA system and then
extended to a group of university medical centers in the private sector. The
authors performed a risk-adjusted outcome analysis of vascular surgical
operations performed in men in VA hospitals compared with the university
private sector medical centers. The study design was a prospective cohort
study of vascular surgical operations in men from 128 VA medical centers
compared with 14 university medical centers. Procedures were performed
between October 1, 2001, and September 30, 2004. The study compared
patient and operative characteristics and unadjusted and adjusted 30-day
morbidity and mortality.
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There were 30,058 vascular operations in men at VA hospitals compared
with 5174 vascular operations inmen in the private sector hospitals.Unadjusted
30-day mortality rate was lower in the VA system (3.4% vs 4.2%, P  .004).
Risk-adjusted mortality was no different between the two hospital types. The
unadjusted 30-day morbidity rate was also lower in the VA system compared
with the private sector (17.3% vs 22.3%, P  .0001). With risk-adjustment,
morbidities still remained lower in the VA system compared with the private
sector (adjusted odds ratio, 0.84; 95% confidence interval, 0.78 to 0.92).
Comment: Physicians in the private sector sometimes malign the VA
system. Although the bureaucracy of the VA system can at times seem
stifling, it has always been my impression that the patients receive excellent
surgical care within the VA system. The results of this report, and others like
it, are not so important in comparing outcomes in VA vs private sector
hospitals, but in validating the concept and utility of the National Surgical
Quality Improvement Program. NSQIP is now the model system for assess-
ment of quality of surgical care.
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